PT3459542T - Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal - Google Patents
Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminalInfo
- Publication number
- PT3459542T PT3459542T PT177996741T PT17799674T PT3459542T PT 3459542 T PT3459542 T PT 3459542T PT 177996741 T PT177996741 T PT 177996741T PT 17799674 T PT17799674 T PT 17799674T PT 3459542 T PT3459542 T PT 3459542T
- Authority
- PT
- Portugal
- Prior art keywords
- prevention
- treatment
- trigeminal neuralgia
- carbamate compound
- carbamate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061386 | 2016-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3459542T true PT3459542T (pt) | 2021-08-24 |
Family
ID=60325324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT177996741T PT3459542T (pt) | 2016-05-19 | 2017-05-18 | Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11207295B2 (https=) |
| EP (1) | EP3459542B1 (https=) |
| JP (1) | JP6960415B2 (https=) |
| KR (1) | KR102421013B1 (https=) |
| CN (1) | CN109310669B (https=) |
| AU (1) | AU2017267160B2 (https=) |
| CA (1) | CA3024284C (https=) |
| DK (1) | DK3459542T3 (https=) |
| ES (1) | ES2887338T3 (https=) |
| MX (1) | MX389613B (https=) |
| PL (1) | PL3459542T3 (https=) |
| PT (1) | PT3459542T (https=) |
| RU (1) | RU2751504C2 (https=) |
| WO (1) | WO2017200317A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3035674T3 (en) | 2016-12-14 | 2025-09-08 | Sk Biopharmaceuticals Co Ltd | Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease |
| US20220117941A1 (en) * | 2018-09-21 | 2022-04-21 | Sk Biopharmaceuticals Co., Ltd. | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
| JP7369185B2 (ja) * | 2018-10-19 | 2023-10-25 | エスケー バイオファーマスティカルズ カンパニー リミテッド | カルバメート化合物の糖尿病性末梢神経障害又は化学療法剤誘発性末梢神経障害の予防、緩和又は治療のための使用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) * | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DE2628420A1 (de) * | 1976-06-24 | 1978-01-05 | Bayer Ag | 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide |
| US5958949A (en) * | 1996-12-31 | 1999-09-28 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of piperidyl thioesters |
| WO2002067922A1 (en) * | 2001-02-27 | 2002-09-06 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in the treatment of pain |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| JP4227121B2 (ja) | 2005-06-08 | 2009-02-18 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| PL2445890T3 (pl) | 2009-06-22 | 2016-02-29 | Sk Biopharmaceuticals Co Ltd | Sposób wytwarzania estru (R)-1-arylo-2-tetrazoliloetylowego kwasu karbaminowego |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US20130252924A1 (en) * | 2010-11-11 | 2013-09-26 | Akron Molecules Gmbh | Compounds and Methods for Treating Pain |
| TN2016000497A1 (en) | 2014-05-09 | 2018-04-04 | Tecnimede Sociedade Tecnico Medicinal S | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine |
-
2017
- 2017-05-16 KR KR1020170060713A patent/KR102421013B1/ko active Active
- 2017-05-18 CA CA3024284A patent/CA3024284C/en active Active
- 2017-05-18 EP EP17799674.1A patent/EP3459542B1/en active Active
- 2017-05-18 US US16/302,860 patent/US11207295B2/en active Active
- 2017-05-18 PT PT177996741T patent/PT3459542T/pt unknown
- 2017-05-18 AU AU2017267160A patent/AU2017267160B2/en active Active
- 2017-05-18 JP JP2018560617A patent/JP6960415B2/ja active Active
- 2017-05-18 CN CN201780030912.5A patent/CN109310669B/zh active Active
- 2017-05-18 WO PCT/KR2017/005172 patent/WO2017200317A1/ko not_active Ceased
- 2017-05-18 DK DK17799674.1T patent/DK3459542T3/da active
- 2017-05-18 RU RU2018144784A patent/RU2751504C2/ru active
- 2017-05-18 MX MX2018014081A patent/MX389613B/es unknown
- 2017-05-18 ES ES17799674T patent/ES2887338T3/es active Active
- 2017-05-18 PL PL17799674T patent/PL3459542T3/pl unknown
-
2021
- 2021-12-02 US US17/457,308 patent/US12611395B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018144784A (ru) | 2020-06-19 |
| CN109310669B (zh) | 2022-02-22 |
| ES2887338T3 (es) | 2021-12-22 |
| AU2017267160B2 (en) | 2022-11-10 |
| KR20170131241A (ko) | 2017-11-29 |
| CA3024284A1 (en) | 2017-11-23 |
| RU2018144784A3 (https=) | 2020-08-11 |
| JP6960415B2 (ja) | 2021-11-05 |
| KR102421013B1 (ko) | 2022-07-14 |
| EP3459542A1 (en) | 2019-03-27 |
| JP2019516722A (ja) | 2019-06-20 |
| WO2017200317A1 (ko) | 2017-11-23 |
| DK3459542T3 (da) | 2021-09-13 |
| MX389613B (es) | 2025-03-20 |
| US20190175555A1 (en) | 2019-06-13 |
| BR112018073556A2 (pt) | 2019-03-19 |
| CA3024284C (en) | 2024-01-23 |
| US20220087976A1 (en) | 2022-03-24 |
| US12611395B2 (en) | 2026-04-28 |
| EP3459542A4 (en) | 2020-01-08 |
| MX2018014081A (es) | 2019-09-02 |
| RU2751504C2 (ru) | 2021-07-14 |
| CN109310669A (zh) | 2019-02-05 |
| EP3459542B1 (en) | 2021-06-30 |
| US11207295B2 (en) | 2021-12-28 |
| AU2017267160A1 (en) | 2018-12-13 |
| PL3459542T3 (pl) | 2021-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269354A (en) | Compounds useful in the treatment or prevention of a prmt5-mediated disorder | |
| LT3334422T (lt) | Kanabidiolio rūgšties panaudojimas epilepsijos gydymui | |
| HUE039809T2 (hu) | Vegyület karbamid-tartalmú mûtrágyák kezelésére | |
| DK3507291T3 (da) | Kondenserede bicykliske sgc-stimulatorer | |
| IL256903A (en) | Gamma secretase modulators for the treatment of immune system dysfunction | |
| IL262487B (en) | Compounds and methods for treating neurological and cardiovascular conditions | |
| IL264143B (en) | Processes for preparing olaparib | |
| EP3457850C0 (en) | SYNERGISTIC COMBINATION OF BIOCIDES | |
| DK3624796T3 (da) | Pyrrolopyridin.anilinforbindelser til behandling af hudlidelse | |
| DK3504187T3 (da) | Anvendelse af pridopidin til behandling af funktionel tilbagegang | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| IL247111A0 (en) | Preventive or therapeutic agent for kidney disease | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
| IL255185A0 (en) | 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto | |
| DK3459543T3 (da) | Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3331610T3 (da) | Midler til anvendelse til behandling af gliom | |
| SI3522880T1 (sl) | Postopki zdravljenja akutne poškodbe ledvic | |
| LT3534885T (lt) | Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui | |
| IL282700A (en) | Heterocyclic compounds for the treatment of epilepsy | |
| PL3297625T3 (pl) | Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek | |
| LT3402474T (lt) | Il-8 inhibitoriai, skirti panaudoti chemoterapijos sukeltos periferinės neuropatijos gydymui | |
| DK3302573T3 (da) | Sammensætning til behandlingen af hjernelæsioner | |
| HUE042043T2 (hu) | Malária megelõzésére vagy kezelésére alkalmas triaminopiridin-vegyületek |